PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview

  1. 3,019 Posts.
    lightbulb Created with Sketch. 1846

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.